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Abstract
Background: Guidelines are the foundation for healthcare planning, delivery and quality improvement but are not
consistently implemented. Few guidelines are accompanied by guideline implementation tools (GItools). Users have
requested GItools, and developers have requested guidance on how to develop GItools. First it is necessary to
characterize GItools. The purpose of this research was to generate a framework of desirable features of GItools.
Methods: Items representing desirable GItool features were generated by a cross-sectional survey of the international
guideline community. Items were confirmed by 31 guideline developers, implementers and researchers in a
two-round Delphi survey administered on the Internet. The resulting GItool framework was applied with a
sample of GItools accompanying guidelines identified in the National Guideline Clearinghouse.
Results: The cross-sectional survey was completed by 96 respondents from Australia, Canada, the United Kingdom,
the United States, The Netherlands, and various other countries. Seven of nine items were rated by the majority
as desirable. A total of 31 panelists from 10 countries including Australia, Canada, Germany, New Zealand, Peru,
Saudi Arabia, Spain, the United Kingdom, and the United States took part in a two-round Delphi survey. Ten items
achieved consensus as desirable GItool features in round #1, and two additional items in round #2. A total of 13
GItools for Resource Planning, Implementation and Evaluation were identified among 149 guidelines on a variety
of clinical topics (8.7%). Many GItools did not possess features considered desirable.
Conclusions: Inclusion of higher quality GItools in guidelines is needed to support user adoption of guidelines.
The GItool framework can serve as the basis for evaluating and adapting existing GItools, or developing new
GItools. Further research is needed to validate the framework, develop and implement instruments by which
developers can apply the framework, and specify which guidelines should be accompanied by GItools.
Keywords: Guidelines, Implementation
Background
Guidelines began to be widely produced in the 1980s by
government agencies and professional societies to address
concerns about practice variations and the safety of bio-
medical technology [1]. They continue to proliferate due
to increased pressure by the public and payers to provide
optimal care [2]. Guidelines are seen as the ‘foundation of
efforts to improve healthcare’ at the micro (individual clin-
ician or patient), meso (group, institution) and macro
(economic, political) level by informing policy, planning,
delivery and evaluation [2,3]. Directories such as the Na-
tional Guideline Clearinghouse (www.guideline.gov) were
created to enhance access to guidelines, and guideline
developers, implementers and researchers formed the
Guidelines International Network (www.g-i-n.net) to ad-
vance guideline development and implementation through
knowledge sharing, research and collaborative efforts. The
recently issued Checklist for Guideline Development pro-
vides an 18-category framework by which to plan and
undertake guideline development and implementation [4].
The Checklist is based on considerable research that
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demonstrates how much the guideline enterprise has
evolved. It draws upon AGREE II, GRADE and GLIA,
which offer principles, standards and criteria for devel-
oping robust and trustworthy guidelines in which the
quantity and quality of evidence is apparent, and recom-
mendations are clearly worded and actionable [5-7].
Numerous appraisal tools have also been developed to
help guideline users assess the quality of guidelines [8].
Despite these improvements in the process of guide-
line development and in the quality of guidelines, their
use remains inconsistent, leading to sub-optimal system,
organization and clinical/patient outcomes. An analysis
of population-based data reflecting 439 recommenda-
tions for 30 conditions spanning preventive, acute and
chronic services found that 54.9% of patients in the
United States received guideline-recommended care [9].
A similar study in the United Kingdom found no im-
provement in patient care following release of guidelines
for a variety of conditions [10]. Surveys of guideline de-
velopers worldwide found that many do not implement
their guidelines and believe that this is the responsibility
of guideline users [11,12]. We interviewed international
guideline developers about their implementation prac-
tices and challenges [13]. This revealed considerable
variability in funding, staffing models and implementa-
tion planning approaches. Most developers disseminated
guidelines on web sites and in academic journals but did
not have funding for more elaborate, proactive or tar-
geted implementation activities.
More recent studies provide some insight on factors
that challenge guideline implementation among users. A
systematic review found wide variation across different
guidelines in reported awareness (28% to 100%), agree-
ment (12.7% to 97%), adoption (11% to 97.4%) and ad-
herence (16.7% to 84.1%) and, even when awareness or
agreement were high, reported adoption and adherence
were comparatively lower [14]. Focus groups and inter-
views with clinicians also found that even with the best
of intentions to implement a guideline, health profes-
sionals were frustrated and at a loss as to how to achieve
that in practice [15]. These studies reveal that guideline
quality, or awareness of and agreement with guidelines
may not pose major hurdles to guideline uptake. Instead,
guideline users require support for implementation.
Others have also suggested that guideline developers pay
greater attention to providing clinicians with tools that
support implementation such as assessment instruments
to identify guideline-specific barriers and corresponding
implementation strategies, or checklists that could be in-
tegrated into clinical decision support systems [16]. This
idea is supported by cognitive science theory, which sug-
gests that guidelines may be difficult to use because they
present complex information recommending action that
may not match patient, provider and organizational
contextual circumstances that often interact to challenge
guideline implementation and use [17]. Empirical re-
search supports this theory. A systematic review found
that compliance with 143 guidelines was greater for
those that included instructions or resources for imple-
menting the recommendations, a tactic to reduce the
complexity of information, and two trials found that
guidelines containing instructions or resources were im-
plemented more than usual guidelines [18-20].
There are several types of guideline implementation
tools (GItools) that provide users with instructions or re-
sources for guideline implementation [21]. These include
support for resource planning (e.g., human resource
planning, costing models); implementation (clinical algo-
rithms, chart documentation forms or checklists, mobile
device resources, pocket guides or reference cards, slide
presentations, staff training material); and evaluation (in-
dicators/performance measures, benchmarks, audit in-
structions). Our interviews with 30 guideline developers
or implementers from government and professional so-
cieties in seven countries found that few had developed
GItools [13]. However, they described a demand for
GItools among target users of their guidelines and re-
quested guidance for developing GItools. We examined
guideline development instructional manuals for infor-
mation on how to develop GItools but most were lack-
ing in this regard, highlighting the need to develop
resources that support GItool adaptation or develop-
ment [22]. This was recently confirmed by a more ex-
pansive review of guideline development instructional
resources [4].
GItools can support guideline implementation, but our
research found that they are not consistently offered in
or with guidelines [13,21]. Developers have requested
guidance on how to develop GItools. Before developing
such guidance, it is first necessary to better characterize
the ideal characteristics of GItools. The primary purpose
of this research was to generate a framework of the de-
sirable features of GItools that could serve as the basis
by which to evaluate and adapt existing GItools, or de-
velop new GItools. A secondary or related purpose was
to apply the framework to describe GItools included in,
or accompanying, a selection of guidelines as a first
measure of the status of the field.
Methods
Overall approach
Items reflecting the desirable features of GItools were first
generated and vetted with a cross-sectional survey of
international guideline developers, implementers and re-
searchers based on standard descriptive survey methods
[23]. Then items were confirmed and expanded by a panel
of international guideline developers, implementers and
researchers through a two-stage Delphi process [24]. The
Gagliardi et al. Implementation Science 2014, 9:98 Page 2 of 9
http://www.implementationscience.com/content/9/1/98
resulting framework was used to describe the features of
GItools accompanying a selection of guidelines. For this
research, GItools were defined as ‘information within or
accompanying guidelines that helps users implement the
recommendations.’ The definition was purposefully broad
to be as inclusive as possible. Three types of GItools were
considered and defined as follows: Resource planning
(equipment or technology needed; industrial standards;
policies governing their use; type and number of health
professionals needed to deliver services; staff education,
training or competencies; anticipated changes in workflow
during or after adoption; associated costs); Implementa-
tion (assessing of individual, organizational and system
barriers associated with adoption; selecting and tailoring
implementation strategies that address barriers; point-of-
care tools in which recommendations are embedded); and
Evaluation (performance measures/quality indicators; in-
structions on how to develop indicators; relevant bench-
marks; instructions by which individuals or organizations
can assess baseline and/or post-adoption performance).
Ethics approval for this research was established at the
University Health Network, Toronto, Canada.
Cross-sectional survey to generate and rate candidate
GItool features
A survey was drafted to generate and rate the desirability
of candidate GItool features. Candidate GItool features
were initially informed by items considered fundamental
to the transparency, reliability and validity of evaluation or
measurement instruments [25]. These included state-
ments about objectives and target users, and details about
development, underlying evidence, and testing. Section
One defined GItools as noted above, and provided URL
links to two examples for each of the three types of
GItools (Resource planning, Implementation, Evaluation)
so that respondents could familiarize themselves with vari-
ous GItools (Table 1). Section Two listed nine GItool fea-
tures. Respondents were asked to rate the desirability of
each feature for assessing or developing GItools on a 7-
point Likert-type scale ranging from ‘strongly disagree’ to
‘strongly agree.’ Free text options were included for com-
ments on the wording or content of items, and to suggest
additional items. The survey was reviewed by the research
team, who suggested minor edits to wording.
The survey was administered using an Internet appli-
cation to members of the Guidelines International Net-
work (G-I-N). G-I-N at the time included 107 individual
and 86 organizations members from 45 countries. Mem-
bers include guideline developers, implementers and re-
searchers. The G-I-N secretariat announced the survey to
G-I-N members via email in July 2012. A reminder was
sent at two weeks and four weeks according to the tailored
design method [26]. Response rate was not calculated
since a denominator could not be accurately established.
Response frequencies were calculated, items rated ‘agree’
or ‘strongly agree’ by 65% or more of respondents were
noted, and comments were summarized.
Delphi consensus process to confirm desirable GItool
features
A survey was developed to establish consensus on desir-
able GItool features. GItools were defined as noted
above along with a URL link to a web site featuring ex-
amples of GItools (http://giranet.org). All nine GItool
features considered in the previous cross-sectional sur-
vey were included. Additional items were generated at a
meeting of Canadian guideline developers in Toronto,
Canada, on May 10, 2013. The meeting was held to so-
licit input on how to characterize GItools. All developers
of Canadian guidelines were initially identified by
searching the Agency for Healthcare Research and Qual-
ity’s Guideline Clearinghouse (http://www.guideline.gov)
and searching MEDLINE for [Canada AND guidelines
as topic]. Participants were recruited to attend the meet-
ing by email invitation. A total of 28 participants were
divided into 5 small groups that each reviewed a differ-
ent GItool with the nine GItool features. Each small
group reported the findings of their review. Then the full
assembly discussed the desirable features of GItools. As
a result, 7 additional GItool features were recommended
Table 1 GItools provided as examples in cross-sectional survey
Type of GItool Examples
Resource Implications Guide to the Implementation of Stroke Unit Care, http://strokebestpractices.ca/wp-content/uploads/
2010/11/CSS-Stroke-Unit-Resource_EN-Final2-for-print.pdf
Pan-Canadian Health Human Resource Planning Toolkit, http://www.nshrf.ca/initiatives/initiatives/
pan-canadian-health-human-resources-planning-toolkit
Implementation Canadian Respiratory Guidelines Toolkit, http://www.respiratoryguidelines.ca/toolkit
Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-cancer Pain Opioid Manager –
Opioid Manager (for EMR), http://nationalpaincentre.mcmaster.ca/opioidmanager/
Evaluation Canadian Stroke Strategy Performance Measurement Manual, http://www.strokebestpractices.ca/
wp-content/uploads/2012/07/CSS-Performance-Manual-2008_EN.pdf
Canadian Association of Radiologists: Maximizing the effectiveness of clinical audits,
http://www.car.ca/uploads/education lifelong learning/201101_en_car_guide_clinicalaudit.pdf
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and added to the original 9 for a total of 16 items in the
survey. Each was to be rated on a 7-point Likert-type
scale ranging from ‘strongly disagree’ to ‘strongly agree.’
A free text option was included for additional items sug-
gested by participants. A panel was assembled comprised
of 31 guideline developers, implementers or researchers
from countries with well-established guideline programs.
They were selected from among G-I-N members for
their expertise, experience or expressed interest in
GItools. They were contacted by email to explain the
process and confirm their participation. The survey was
administered using an Internet application. A reminder
was sent at two weeks and four weeks [26]. Frequencies
of panel responses were calculated to establish the de-
gree of consensus for each item. Standard Delphi proto-
col suggests that two or three rounds of rating with
agreement by two thirds of panelists will prevent respond-
ent fatigue and drop-out while establishing reasonable
consensus [27,28]. The following consensus categories
were applied: strong consensus for acceptance (20 or more
panel members agreed or strongly agreed by choosing 6
or 7), strong consensus for exclusion (20 or more panel
members disagreed or strongly disagreed by choosing 1 or
2) and unclear consensus (20 or more panel members
chose 3, 4, 5 or ‘Not Sure’). Newly suggested criteria were
noted. A Round #1 report was prepared summarizing
anonymized rating frequencies and comments, grouping
criteria by consensus category, and listing newly suggested
criteria. The Round #1 report was returned to panelists by
email along with a link to the Round #2 questionnaire for-
matted similar to that in Round #1 for rating of items that
had not yet achieved consensus for inclusion or exclusion.
Similar analysis was performed to summarize Round #2
results. The Delphi process took place during June and
July of 2013. This generated a list of GItool features con-
sidered desirable according to the consensus of inter-
national experts.
Description of features of a sample of GItools
Guidelines were identified in the Guideline Clearing-
house in June and July of 2012. This resource contains
approximately 2,500 guidelines. For feasibility, guidelines
were sampled by clinical topic including arthritis, breast
cancer, diabetes, stroke, angina, asthma, depression, and
prostate cancer. These topics were selected because they
are major causes of disability and death worldwide and
affect both men and women. Eligible guidelines ad-
dressed overall management of these conditions, and
were produced within five years by organizations having
developed at least 10 guidelines. Full text guidelines
were examined, as was the content of corresponding de-
veloper web sites to identify information or resources
considered to be a GItool. For this analysis, GItools were
defined as noted earlier. One research assistant initially
identified eligible guidelines in the Guideline Clearing-
house. Two research assistants independently identified
potential GItools within guidelines or on corresponding
developer web sites. The principal investigator and an
RA together reviewed these to confirm they could be
considered GItools. Two research assistants independ-
ently assessed each GItool for GItool features according
to the consensus items generated by the Delphi process.
Data were tabulated and summarized to describe the
number and type of GItools with features considered
desirable.
Results
Cross-sectional survey to generate and rate candidate
GItool features
The survey was fully completed by 96 respondents from
Australia (37.5%), Canada (17.7%), United Kingdom
(6.25%), United States (7.3%), The Netherlands (7.3%),
various other countries (16.7%), and not indicated
(7.3%). Of these, 65.6% were developers, 50.0% imple-
menters, 41.7% researchers, 18.8% other, and 15.6% indi-
cated no position. Of nine items presented, 65% or more
of respondents agreed or strongly agreed that seven rep-
resented desirable GItool features (Table 2). Of the
remaining, one was rated ‘agree’ or ‘strongly agree’ by
63.8% (GItool development is clearly described). Rating
was variable for full-scale evaluation of GItools (#8),
which did not achieve consensus as a desirable feature
(44.7% agree or strongly agree).
No new items were suggested. All features were con-
sidered desirable, but several respondents commented
on whether it was feasible to develop GItools with all of
these features: ‘this is the gold standard, not sure
whether it is achievable’ and ‘the criteria are ideal, in
practice it will be hard to achieve.’ A few respondents
said that developers may not have the resources for
pilot-testing or more comprehensive evaluation, and that
simple GItools may not require rigorous evaluation. This
was corroborated by others who said that (see Table 2)
#1 to #5 were essential requirements when developing
GItools, #6 and #7 were important but not essential if
resources were limited, and #8 would be a lower priority
but compensated for by prospective evaluation (#9). A
few respondents said that rigorous testing would require
considerable time and delay the use of GItools that
would otherwise improve care delivery and outcomes,
further emphasizing the benefit of making less-
rigorously developed GItools available, and the value of
prospective evaluation. Views were not uniform. For ex-
ample, one respondent said that prospective evaluation
may not be possible because GItools that were not useful
would be rapidly discarded, and another respondent said
that implementation of GItools with unknown impact
should be actively discouraged.
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Delphi consensus process to confirm desirable GItool
features
A total of 31 panelists from 10 countries including
Australia, Canada, Germany, New Zealand, Peru, Saudi
Arabia, Spain, the United Kingdom, and the United
States completed survey #1. Of these, 30 panelists from
nine countries complete survey #2. Results are summa-
rized in Table 3. In round #1, 65% of panelists agreed or
strongly agreed that 10 of 16 GItool features were desir-
able, and 8 new features were suggested. In round #2,
six features that did not achieve favourable consensus in
round #1 were re-rated. Of these, 65% of panelists
agreed or strongly agreed with one (prospective collec-
tion of user feedback). Of the eight newly suggested fea-
tures that were rated in round #2, 65% or more of
panelists agreed or strongly agreed with one (reporting
of context or setting in which tool developed/used).
Table 4 lists the final 12 GItool features considered
desirable.
Five panelists commented that all features were essen-
tial. One panelist said that it was important not to limit
access to GItools without all features, noting that many
would be adapted and improved by others. Another pan-
elist said that features achieving consensus on desirabil-
ity could be considered ‘key’ and the rest labeled as ‘nice
to have.’ Another panelist said GItools could be made
available after pilot testing and that full scale evaluation
was better done by those who did not develop the tool.
Another respondent said that if GItools were shared in a
database, users or developers could prospectively post
comments such that the original developers or others
could improve the GItool based on this feedback.
Description of features of a sample of GItools
A search of the Guidelines Clearinghouse identified 149
guidelines on the overall management of arthritis, breast
cancer, diabetes, stroke, angina, asthma, depression, and
prostate cancer produced within five years by organiza-
tions having developed at least 10 guidelines. A search
of the content of each guideline and the developer’s web
site identified a total of 13 GItools among 149 guidelines
(8.7%). This included four Resource planning, seven Im-
plementation, and two Evaluation GItools. Each GItool,
the associated guideline and the developer’s web site
were searched for information pertaining to each desir-
able GItool feature (Table 5). Overall, most GItools
named target users (92.3%) and described development
methods (84.6%); a moderate number of GItools re-
ported or provided objectives (53.8%), instructions
(61.5%), search strategy for sources of content (53.8%),
sources of content (61.5%), context in which tool was
developed or will be used (53.8%), and how target users
were involved in development (53.8%); few GItools de-
scribed underlying evidence (23.1%); methods used to
evaluate the GItool (7.7%), or whether prospective feed-
back about GItool use was gathered (30.8%); and no
Table 2 Cross-sectional survey to generate and rate desirable GItool features (n = 96)
GItool feature Rating (n,%)
1 2 3 4 5 6 7 Unsure 6 + 7
1. Tool objectives are stated 0 1 0 2 5 22 66 0 88
0.0 1.0 0.0 2.1 5.2 22.9 65.3 0.0 91.7
2. Target users of tool are identified 0 1 1 4 6 19 65 0 84
0.0 1.0 1.0 4.2 6.3 19.8 67.8 0.0 87.5
3. Tool development is clearly described 0 1 6 5 20 17 45 2 62
0.0 1.0 6.3 5.2 20.8 17.7 46.9 2.1 64.6
4. Evidence is cited that underpins tool design, development, content 1 0 4 12 11 19 49 0 68
1.0 0.0 4.2 12.5 11.5 19.8 51.0 0.0 70.8
5. Quantity and quality of underpinning evidence is described 1 2 2 15 12 22 40 2 62
1.0 2.1 2.1 15.6 12.5 22.9 41.7 2.1 64.6
6. Development involved pre-testing (gathering stakeholder needs
and suggestions by interview, focus group, survey, etc.)
3 2 0 6 13 29 39 4 68
3.1 2.1 0.0 6.3 13.5 30.2 40.6 4.2 70.8
7. Development involved pilot-testing with stakeholders to assess
use and satisfaction, and then improve the tool
1 3 2 3 11 25 46 5 71
1.0 3.1 2.1 3.1 11.5 26.0 47.9 5.2 74.0
8. Development involved full-scale evaluation with a larger sample
of stakeholders to thoroughly/rigorously assess impact
1 2 9 12 24 19 23 6 42
1.0 2.1 9.4 12.5 25.0 19.8 24.0 6.3 43.8
9. Once implemented, user feedback is prospectively collected
to monitor tool use and impact
0 1 3 4 14 30 42 2 72
0.0 1.0 3.1 4.2 14.6 31.3 43.8 2.1 75.0
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GItools mentioned pilot-testing of the GItool with target
users. Inclusion of this information in GItools across cat-
egories of GItools was variable.
Discussion
The primary purpose of this research was to characterize
the ideal features of GItools. This work is unique be-
cause existing instruments and criteria are specific to
the development or appraisal of high quality guidelines
and not accompanying GItools that are meant to support
implementation of guideline recommendations [5-8]. The
international guideline community including developers,
implementers and researchers were engaged in generating
a 12-item framework of desirable GItool features. All fea-
tures were considered important, and one respondent said
that implementation or use of GItools with unknown im-
pact should be discouraged. Many respondents said that
while ideal, addressing items pertaining to evaluation of
GItools may not be feasible for guideline developers given
limited time and resources. Pilot-testing with target users
was considered important, but full scale evaluation less so.
In part, this was due to the feasibility of evaluation, and in
part respondents did not want to limit access to GItools.
Instead they thought that GItools would likely be adapted
and improved upon release, and that a centralized reposi-
tory should be developed to collect experiences from users
that could inform improvement of GItools by developers,
researchers or other users. A secondary or related purpose
of this research was to describe GItools accompanying a
selection of guidelines using the GItool framework. A total
of 13 GItools were identified among 149 guidelines on a
variety of clinical topics (8.7%). Many did not possess
most of the features considered desirable by the inter-
national guideline community.
Interpretation and application of these findings may be
limited by several factors. We may have failed to identify
all possible GItool features, not all individuals with ex-
pertise in guideline development and implementation
may have been engaged, and we may not have accurately
characterized GItools using the framework of desirable
features. However, we solicited opinions through G-I-N,
which represents and reaches guideline developers, im-
plementers and researchers worldwide, and several indi-
viduals independently analyzed GItools for the desirable
features. One respondent noted that all items may not
be applicable to different types of GItools. Further use of
Table 3 Delphi survey to confirm desirable GItool featuresGItool feature
Round #1 Round #2
1. Tool objectives are stated 28 (90.3) —
2. Target users of tool are identified 27 (87.1) —
3. Methods used to develop the tool are clearly described 21 (67.7) —
4. Instructions are provided on how to use the tool 28 (90.3) —
5. Conflicts of interest of those involved in tool development are disclosed 19 (61.3) 19 (63.3)
6. Target users informed tool content and format (survey, interview, focus group, committee) 22 (71.0) —
7. Experts in tool content, and instrument development and design were involved in tool development 19 (61.3) 13 (43.3)
8. A comprehensive literature review was undertaken to inform and assemble tool content 23 (74.2) —
9. Sources are cited for evidence upon which tool content is based 23 (74.2) —
10. Quantity and quality of evidence upon which tool content is based is described 20 (64.5) —
11. The tool was pilot-tested with users and refined based on their feedback prior to implementation 22 (71.0) —
12. Pilot-testing was rigorous (appropriate sampling, methods) 17 (54.8) 15 (50.0)
13. A description is included of how the tool was evaluated 20 (64.5) —
14. Tool effectiveness was assessed by full scale evaluation of impact on clinicians and/or patients 15 (48.4) 8 (26.7)
15. Full scale evaluation was rigorous (appropriate sampling, methods) 15 (48.4) 12 (40.0)
16. User feedback about tool use and impact is prospectively collected 15 (48.4) 20 (66.7)
17. The type of tool (domain, subdomain) are specified — 16 (53.3)
18. The theoretical basis or rationale for the tool is described — 11 (36.7)
19. Electronic versions are available for computer or mobile device application — 13 (43.3)
20. Experts in the context/setting in which tool will be used were involved in development — 18 (60.0)
21. Details of the context/setting in which tool was developed/will be used are described — 20 (66.7)
22. Success factors/learning based on tool use or evaluation are described — 14 (46.7)
23. Impact was assessed with rapid cycle testing (i.e., PDSA, different from full scale research) — 7 (23.3)
24. The meaning of full scale evaluation results are interpreted based on an implementation threshold — 6 (20.0)
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the framework to evaluate GItools of different types is
needed to ascertain this, and to either highlight the fea-
tures relevant to certain types of GItools, or reveal add-
itional features specific to certain types of GItools. The
GItool framework reflects the views of guideline devel-
opers, implementers and researchers. While some of
these individuals may also be guideline users, further
validation of the desirable features is needed through
direct consultation with target users of guidelines, and
by asking guideline users to assess the relevance and use
of GItools that do and do not possess the desirable
features.
While further validation may be warranted, this re-
search served as a baseline assessment of the current
status of GItools and found that the GItools examined
lacked many of the features considered desirable by the
international guideline community. The resulting frame-
work could therefore function as the basis for evaluating
Table 5 Features of a sample of GItools
GItool feature GItool features Total n (%)
Resource planning (4) Implementation (7) Evaluation (2)
1. Tool objectives are stated 2 4 1 7 (53.8)
2. Target users are named 3 7 2 12 (92.3)
3. Instructions on tool use are provided 4 2 2 8 (61.5)
4. Methods used to develop the tool are described 4 5 2 11 (84.6)
5. Tool is based on a comprehensive search of sources for content 4 3 0 7 (53.8)
6. Evidence upon which tool content is based is described 2 0 1 3 (23.1)
7. Sources of evidence are cited 4 2 2 8 (61.5)
8. Context or setting in which tool was developed/will be
used are described
4 2 1 7 (53.8)
9. Target users were involved in tool development 4 2 1 7 (53.8)
10. Methods used to evaluate the tool are described 0 0 1 1 (7.7)
11. The tool was pilot-tested with users 0 0 0 0 (0.0)
12. User feedback about tool use and impact is prospectively collected 2 1 1 4 (30.8)
Table 4 GItool features considered desirable by the international guideline community
Component Definition/Examples
1. Tool objectives are stated The purpose of the tool is described including
intent, use and desired impact or outcome
2. Target users are named Individuals or groups meant to implement and/or
apply the tool are identified
3. Instructions on tool use are provided Detailed instructions are provided for how
to implement and use the tool
4. Methods used to develop the tool are described Methods used to develop the tool are clearly described,
including the process and those involved
5. Tool is based on a comprehensive search of sources for content A comprehensive literature review was undertaken to
inform and assemble tool content and format
6. Evidence upon which tool content is based is described Quantity and quality of evidence upon which tool
content and format is based is described
7. Sources of evidence are cited Sources are cited for evidence upon which
tool content and format are based
8. Context or setting in which tool was developed/will be used are described Details of the context or setting in which the tool
was developed or is meant to be used are described
9. Target users were involved in tool development Target users were consulted by survey, interview,
focus group or as planning committee members
10. Methods used to evaluate the tool are described Methods used to evaluate the content, format,
use and/or impact of the tool are described
11. The tool was pilot-tested with users The tool was pilot-tested with users and refined based
on their input before broad implementation
12. User feedback about tool use and impact is prospectively collected A mechanism was established to prospectively gather
feedback from users about use and impact
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and adapting existing GItools, or developing new GItools
that describe not only the objectives and target users, but
also provide details about their development, sources of
content, evaluation, and potential impact.
Guideline developers may experience a number of bar-
riers in applying the GItool framework. For example, op-
tions and instructions for operationalizing each element
may be needed. Work is ongoing to translate this frame-
work into an instrument or toolkit by which developers
can evaluate and adapt, or develop new GItools. The
need for such guidance was confirmed by Schunemann
et al., who reviewed guideline development and instruc-
tional manuals, several of which noted the need to de-
velop or adapt tools or derivative products to provide
guidance on how the recommendations can be imple-
mented in practice, but provided limited information on
how to achieve that [4]. The GItool framework gener-
ated by this research serves as the first step in develop-
ing more detailed guidance.
In previous research, guideline developers noted that
limited funding challenged guideline implementation
[11-13]. In this research, though respondents believed
that all GItool features were important, they noted that
lack of funding would limit their capacity to address
GItool framework elements related to pilot-testing or
evaluating GItools, or prospectively gathering user feed-
back. It appears that some evaluation of GItools in the
form of pilot-testing with target users prior to release is
considered warranted. Pilot-testing can be variable in
scope and rigour. For example, pilot-testing could con-
sist of review by a few target users, or use of the GItool
for a period of time by a few users, or more rigorous
evaluation among a large number of different types of
target users. Further analysis of the extent and methods
of pilot-testing needed for different types of GItools may
be needed. This information could help guideline devel-
opers plan, prioritize, and budget for pilot-testing.
An alternative means for addressing the barrier of lim-
ited funding is to draw on the principles and practices of
action research or integrated knowledge translation, which
could be used to establish researcher-developer partner-
ships for the purpose of evaluating GItools through pilot-
testing [29,30]. Participants thought that shared develop-
ment of GItools was a feasible way to more rigorously
evaluate and improve GItools. This could be achieved by
releasing GItools and then prospectively collecting feed-
back from users upon which developers or others could
improve them. While we developed a repository of GItools
(http://giranet.org), this was done as a means of providing
examples of different types of GItools. Growing and sus-
taining such a database may not be possible. It may be
more feasible to integrate the GItool framework or a
mechanism for feedback about GItools into existing re-
positories of guidelines.
We identified few GItools (8.7%) among the guidelines
that were examined despite sampling guidelines on a
range of topics. The number of guidelines examined rep-
resented approximately 6.0% of the guidelines in the Na-
tional Guideline Clearinghouse so additional guidelines
could be sampled to identify a larger number of GItools
that could be evaluated according to the GItool frame-
work. However, it appears that few GItools possess many
of the features considered desirable. Broad dissemination
of the GItool framework among developers may be
needed to prompt the adaptation or development of
GItools. In this regard, several questions remain to be
addressed by further research. For example, should all
guidelines be accompanied by one or more GItools?
Which types of GItools are most suitable for different
guidelines? Ongoing research could also explore the
challenges faced by developers when adapting or devel-
oping GItools so that suitable solutions can be identified.
Ultimately, the impact of GItools featuring desirable
characteristics could be evaluated.
While many questions requiring additional research
are posed here, the GItool framework generated through
consultation with the international guideline community
represents the current gold standard for assessing or de-
veloping GItools. Practical application of the GItool
framework may lead to the inclusion of higher quality
GItools with more guidelines that may support broader
and more consistent implementation and use of guide-
lines by target users.
Conclusions
Consultation with and engagement of international guide-
line developers, implementers and researchers generated
a 12-item framework of desirable features of GItools.
Among a sample of guidelines, few GItools were identi-
fied. Examination of GItools with this framework found
that few possessed features considered desirable by the
guideline community. Further research is needed to valid-
ate the framework, develop and implement instruments
by which developers can apply the framework, and specify
which guidelines should be accompanied by GItools.
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